Cargando…

Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome

BACKGROUND: Although myocardial infiltration with leukemic blasts is a known finding in patients with acute leukemia, this phenomenon in myelodysplasia is not reported in the literature. Cardiac symptoms in patients with myelodysplasia are often due to anemia and may be due to iron overload and side...

Descripción completa

Detalles Bibliográficos
Autores principales: Mateen, Farrah J, Harding, Sheila R, Saxena, Anurag
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1569821/
https://www.ncbi.nlm.nih.gov/pubmed/16953890
http://dx.doi.org/10.1186/1471-2326-6-4
_version_ 1782130214521798656
author Mateen, Farrah J
Harding, Sheila R
Saxena, Anurag
author_facet Mateen, Farrah J
Harding, Sheila R
Saxena, Anurag
author_sort Mateen, Farrah J
collection PubMed
description BACKGROUND: Although myocardial infiltration with leukemic blasts is a known finding in patients with acute leukemia, this phenomenon in myelodysplasia is not reported in the literature. Cardiac symptoms in patients with myelodysplasia are often due to anemia and may be due to iron overload and side effects of therapy. CASE PRESENTATION: Herein we report the first case of neoplastic infiltration of the heart with associated myocardial necrosis in a patient with myelodysplasia. It was associated with unicellular and multifocal geographic areas of necrosis in the left ventricle and the interventricular septum. It is likely that cardiac compromise in our patient was due to a combination of restrictive cardiomyopathy due to leukemic infiltration, concomitant anemia, cardiac dilatation, conduction blocks and myocardial necrosis. Myocardial necrosis was most likely due to a combination of ischemic damage secondary to anemia and prolonged hypotension and extensive leukemic infiltration. Markedly rapid decrease in ejection fraction from 66% to 33% also suggests the role of ischemia, since leukemic infiltration is not expected to cause this degree of systolic dysfunction over a 24-hour period. The diagnosis was not suspected during life due to concomitant signs and symptoms of anemia, pulmonary infections, and pericardial and pleural effusions. The patient succumbed to cardiac failure. CONCLUSION: Hemopoietic cell infiltration was not considered in the differential diagnosis and contributed to this patient's morbidity and mortality. This case highlights the clinical importance of considering myocardial infiltration in patients with myelodysplasia and cardiac symptoms.
format Text
id pubmed-1569821
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15698212006-09-16 Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome Mateen, Farrah J Harding, Sheila R Saxena, Anurag BMC Blood Disord Case Report BACKGROUND: Although myocardial infiltration with leukemic blasts is a known finding in patients with acute leukemia, this phenomenon in myelodysplasia is not reported in the literature. Cardiac symptoms in patients with myelodysplasia are often due to anemia and may be due to iron overload and side effects of therapy. CASE PRESENTATION: Herein we report the first case of neoplastic infiltration of the heart with associated myocardial necrosis in a patient with myelodysplasia. It was associated with unicellular and multifocal geographic areas of necrosis in the left ventricle and the interventricular septum. It is likely that cardiac compromise in our patient was due to a combination of restrictive cardiomyopathy due to leukemic infiltration, concomitant anemia, cardiac dilatation, conduction blocks and myocardial necrosis. Myocardial necrosis was most likely due to a combination of ischemic damage secondary to anemia and prolonged hypotension and extensive leukemic infiltration. Markedly rapid decrease in ejection fraction from 66% to 33% also suggests the role of ischemia, since leukemic infiltration is not expected to cause this degree of systolic dysfunction over a 24-hour period. The diagnosis was not suspected during life due to concomitant signs and symptoms of anemia, pulmonary infections, and pericardial and pleural effusions. The patient succumbed to cardiac failure. CONCLUSION: Hemopoietic cell infiltration was not considered in the differential diagnosis and contributed to this patient's morbidity and mortality. This case highlights the clinical importance of considering myocardial infiltration in patients with myelodysplasia and cardiac symptoms. BioMed Central 2006-09-05 /pmc/articles/PMC1569821/ /pubmed/16953890 http://dx.doi.org/10.1186/1471-2326-6-4 Text en Copyright © 2006 Mateen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mateen, Farrah J
Harding, Sheila R
Saxena, Anurag
Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome
title Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome
title_full Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome
title_fullStr Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome
title_full_unstemmed Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome
title_short Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome
title_sort extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1569821/
https://www.ncbi.nlm.nih.gov/pubmed/16953890
http://dx.doi.org/10.1186/1471-2326-6-4
work_keys_str_mv AT mateenfarrahj extensivemyocardialinfiltrationbyhemopoieticprecursorsinapatientwithmyelodysplasticsyndrome
AT hardingsheilar extensivemyocardialinfiltrationbyhemopoieticprecursorsinapatientwithmyelodysplasticsyndrome
AT saxenaanurag extensivemyocardialinfiltrationbyhemopoieticprecursorsinapatientwithmyelodysplasticsyndrome